Dentatorubral and pallidoluylsian atrophy (DRPLA) is a progressive neurological disorder characterized by neuronal degeneration, especially in the cerebellar dentate nucleus. DRPLA is caused by an unstable expansion of a CAG trinucleotide repeat coding for glutamine in a gene of unknown function, termed atrophin-1, located on chromosome 12. To gain additional understanding of atrophin-1, we have isolated a second member of the atrophin-1 gene family by screening rat cDNA libraries. The 1006-amino-acid product of this gene, which we have termed rat atrophin related protein(rARP), does not contain a glutamine repeat, but it does contain two regions of alternating acidic and basic amino residues similar to those found in atrophin-1. rARP is widely expressed as both a 7.4-and a 9.4-kb message, with enrichment in cerebellum and testis. Like atrophin-1, the rARP in vitro translation product migrates more slowly on SDS-polyacrylamide gel electrophoresis than predicted by molecular weight. We conclude that, at least in the rat, polyglutamine is not an essential feature of the atrophin family of genes. r
INTRODUCTION
Dentatorubral and pallidoluyisian atrophy (DRPLA) is a progressive neurodegenerative disorder with clinical features of cerebellar ataxia, choreoathetosis, myoclonic epilepsy, and dementia. Neuronal loss and gliosis are most severe in the dentate nucleus of the cerebellum and in the globus pallidus, with less profound atrophy in the caudate and putamen (Naito & Oyanagi, 1982; Ross, 1995; Smith et al., 1958) . DRPLA is caused by an unstable expansion of a CAG repeat coding for glutamine in a gene (located on chromosome 12) originally identified as CTG B-37 and now termed atrophin-1 (Koide et al., 1994a; Li et al., 1993; Margolis et al., 1996; Nagafuchi et al., 1994; Onodera et al., 1995) . Patients with Haw River syndrome, a disease phenotypically similar to DRPLA found in a North American pedigree, also have a CAG expansion in atrophin-1 (Burke et al., 1994) . Expanded repeats in the atrophin-1 gene tend to increase in length in successive generations if paternally transmitted (Koide et al., 1994b) . This phenomenon, coupled with the inverse correlation between repeat length and disease age of onset, provides an explanation for the phenomenon of genetic anticipation observed in DRPLA (Komure et al., 1995) .
Four other neurodegenerative diseases also result from an expansion of a CAG repeat coding for glutamine: X-linked spinal and bulbar muscular atrophy (SBMA) (La Spada et al., 1991) , Huntington's disease (HD) (Huntington's Disease Collaborative Research Group, 1993) , spinocerebellar atrophy type 1 (SCA1) (Orr et al., 1993) , and Machado-Joseph disease (SCA3) (Kawaguchi et al., 1994) . Like DRPLA, each of these diseases is believed to result from a pathologic gain-offunction arising from the expanded glutamine repeat (Albine & Tagle 1995; Gusella et al., 1993; Ross, 1995;  
